BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 10096254)

  • 21. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
    Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
    Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.
    Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ
    Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
    Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
    Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
    Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
    EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotype, mRNA expression, and gene structure of p53 in Wilms' tumors.
    el Bahtimi R; Hazen-Martin DJ; Re GG; Willingham MC; Garvin AJ
    Mod Pathol; 1996 Mar; 9(3):238-44. PubMed ID: 8685221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases.
    Re GG; Hazen-Martin DJ; El Bahtimi R; Brownlee NA; Willingham MC; Garvin AJ
    Int J Cancer; 1999 Apr; 84(2):192-200. PubMed ID: 10096254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The roles of microRNAs in Wilms' tumors.
    Yu X; Li Z; Chan MT; Wu WK
    Tumour Biol; 2016 Feb; 37(2):1445-50. PubMed ID: 26634744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teratoid Wilms' tumor: a case report with literature review.
    Inoue M; Uchida K; Kohei O; Nashida Y; Deguchi T; Komada Y; Kusunoki M
    J Pediatr Surg; 2006 Oct; 41(10):1759-63. PubMed ID: 17011284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group.
    Faria P; Beckwith JB; Mishra K; Zuppan C; Weeks DA; Breslow N; Green DM
    Am J Surg Pathol; 1996 Aug; 20(8):909-20. PubMed ID: 8712292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNAs Role in Wilms tumor pathogenesis: Signaling pathways interplay.
    Alfaifi J
    Pathol Res Pract; 2024 Apr; 256():155254. PubMed ID: 38460245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress of fundamental research in Wilms' tumor.
    Wen JG; van Steenbrugge GJ; Egeler RM; Nijman RM
    Urol Res; 1997; 25(4):223-30. PubMed ID: 9286029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, Histological, Cytogenetic and Molecular Analysis of Monozygous Twins with Wilms Tumor.
    Iwańczyk K; Czachowski B; Sosnowska-Sienkiewicz P; Telman G; Ciążyńska P; Mańkowski P; Januszkiewicz-Lewandowska D
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-coding RNAs in Wilms' tumor: biological function, mechanism, and clinical implications.
    de Sá Pereira BM; Montalvão de Azevedo R; da Silva Guerra JV; Faria PA; Soares-Lima SC; De Camargo B; Maschietto M
    J Mol Med (Berl); 2021 Aug; 99(8):1043-1055. PubMed ID: 33950291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrarenal Wilms' tumor of the uterus.
    Jiskoot P; Aertsens W; Degels MA; Moerman P
    Eur J Gynaecol Oncol; 1999; 20(3):195-7. PubMed ID: 10410884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms' tumor development.
    Perbal B
    Crit Rev Oncog; 1994; 5(6):589-613. PubMed ID: 8519812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New developments in the pathology of Wilms tumor.
    Beckwith JB
    Cancer Invest; 1997; 15(2):153-62. PubMed ID: 9095211
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.